These inflammatory mediators can activate the NF-κB pathway, stimulating OC secretion of lysosomal enzymes, thereby accelerating bone resorption and contributing to conditions such as osteoporosis [3, 74]. This evidence concerns the gene NFKB1 and osteoporosis.